172
Participants
Start Date
February 15, 2017
Primary Completion Date
April 17, 2025
Study Completion Date
June 30, 2026
Magnetic Resonance Fingerprinting
Non-contrast MRF acquisition will be acquired through the region of tumor in all patients. For patients receiving intravenous gadolinium based contrast, a post contrast MRF acquisition will also be acquired. This acquisition will be skipped in patients who do not receive or are not eligible for receiving IV contrast as a part of their clinical scan. The research scan will take approximately 10-15 minutes
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Case Comprehensive Cancer Center
OTHER